Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share stock (OACC) is currently trading at $10.70. WallStSmart rates OACC as Sell.
- OACC PE ratio analysis and historical PE chart
- OACC PS ratio (Price-to-Sales) history and trend
- OACC intrinsic value — DCF, Graham Number, EPV models
- OACC stock price prediction 2025 2026 2027 2028 2029 2030
- OACC fair value vs current price
- OACC insider transactions and insider buying
- Is OACC undervalued or overvalued?
- Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share financial analysis — revenue, earnings, cash flow
- OACC Piotroski F-Score and Altman Z-Score
- OACC analyst price target and Smart Rating
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share
📊 No data available
Try selecting a different time range
Smart Analysis
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) · 2 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in institutional own.. Concerns around market cap. Significant fundamental concerns warrant caution or avoidance.
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) Key Strengths (1)
90.40% of shares held by major funds and institutions
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) Areas to Watch (1)
Micro-cap company with very limited liquidity and high volatility
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) Detailed Analysis Report
Overall Assessment
This company scores 10/100 in our Smart Analysis, earning a F grade. Out of 2 metrics analyzed, 1 register as strengths (avg 10.0/10) while 1 fall into concern territory (avg 3.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Institutional Own..
The Bear Case
The primary concerns are Market Cap.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Market Cap improves, as this is the primary drag on the overall score. Second, overall profitability trends. Third, top-line growth trajectory.
Risk Considerations
Based on the metric profile, this is a higher risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Market Cap are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
OACC Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 11:50:08 AM
About Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share(OACC)
NASDAQ
FINANCIAL SERVICES
SHELL COMPANIES
USA
Oaktree Acquisition Corp. III (OACC) is a special purpose acquisition company (SPAC) focused on merging with innovative businesses within the life sciences sector. With a highly experienced management team proficient in healthcare investments, OACC aims to harness growth opportunities across various subfields, including healthcare technology, therapeutics, and medical devices. The company emphasizes strategic partnerships and robust due diligence to enhance shareholder value, while its commitment to operational excellence positions it to thrive amid the complexities of the dynamic life sciences landscape.